“Genetic Polymorphism & Methotrexate Therapy Outcomes in Rheumatoid Arthritis”, Precis. Med. Com., vol. 3, no. 1, pp. 05–09, Jun. 2023, doi: 10.55627/pmc.003.01.0317.